InvestorsHub Logo
Followers 20
Posts 1673
Boards Moderated 0
Alias Born 08/29/2013

Re: None

Wednesday, 03/26/2014 10:08:25 PM

Wednesday, March 26, 2014 10:08:25 PM

Post# of 106837
http://www.noodls.com/view/C1830427718075AF283D429549E7B20FF78FE74C?1801xxx1395844551

This talks about cardio3 and remember Myocell outperformed C-Cure 95 to 52 in the walk test.

This is Bioheart's closest competitor who had a successful IPO last year to get funding for their phase 3.

This is getting exciting!